Literature DB >> 23983217

Current knowledge on cannabinoids in oral fluid.

Dayong Lee1, Marilyn A Huestis.   

Abstract

Oral fluid (OF) is a new biological matrix for clinical and forensic drug testing, offering non-invasive and directly observable sample collection reducing adulteration potential, ease of multiple sample collections, lower biohazard risk during collection, recent exposure identification, and stronger correlation with blood than urine concentrations. Because cannabinoids are usually the most prevalent analytes in illicit drug testing, application of OF drug testing requires sufficient scientific data to support sensitive and specific OF cannabinoid detection. This review presents current knowledge of OF cannabinoids, evaluating pharmacokinetic properties, detection windows, and correlation with other biological matrices and impairment from field applications and controlled drug administration studies. In addition, onsite screening technologies, confirmatory analytical methods, drug stability, and effects of sample collection procedure, adulterants, and passive environmental exposure are reviewed. Delta-9-tetrahydrocannabinol OF concentrations could be >1000 µg/L shortly after smoking, whereas minor cannabinoids are detected at 10-fold and metabolites at 1000-fold lower concentrations. OF research over the past decade demonstrated that appropriate interpretation of test results requires a comprehensive understanding of distinct elimination profiles and detection windows for different cannabinoids, which are influenced by administration route, dose, and drug use history. Thus, each drug testing program should establish cut-off criteria, collection/analysis procedures, and storage conditions tailored to its purposes. Building a scientific basis for OF testing is ongoing, with continuing OF cannabinoids research on passive environmental exposure, drug use history, donor physiological conditions, and oral cavity metabolism needed to better understand mechanisms of cannabinoid OF disposition and expand OF drug testing applicability. Published 2013. This article is a U.S. Government work and is in the public domain in the USA. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  cannabinoid; cannabis; delta-9-tetrahydrocannabinol; marijuana; oral fluid; saliva

Mesh:

Substances:

Year:  2013        PMID: 23983217      PMCID: PMC4532432          DOI: 10.1002/dta.1514

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  217 in total

1.  Neuropsychological performance in long-term cannabis users.

Authors:  H G Pope; A J Gruber; J I Hudson; M A Huestis; D Yurgelun-Todd
Journal:  Arch Gen Psychiatry       Date:  2001-10

2.  Oral fluid drug tests: effects of adulterants and foodstuffs.

Authors:  Raphael C Wong; Minhchau Tran; James K Tung
Journal:  Forensic Sci Int       Date:  2005-06-10       Impact factor: 2.395

Review 3.  Saliva composition and functions: a comprehensive review.

Authors:  Patricia Del Vigna de Almeida; Ana Maria Trindade Grégio; Maria Angela Naval Machado; Antonio Adilson Soares de Lima; Luciana Reis Azevedo
Journal:  J Contemp Dent Pract       Date:  2008-03-01

4.  Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwipe 5+® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis.

Authors:  Sabina Strano-Rossi; Erika Castrignanò; Luca Anzillotti; Giovanni Serpelloni; Roberto Mollica; Franco Tagliaro; Jennifer P Pascali; Delfina di Stefano; Roberto Sgalla; Marcello Chiarotti
Journal:  Forensic Sci Int       Date:  2012-05-01       Impact factor: 2.395

Review 5.  The validity of self-reported drug use in survey research: an overview and critique of research methods.

Authors:  L Harrison
Journal:  NIDA Res Monogr       Date:  1997

6.  Detection of delta 9-tetrahydrocannabinol in saliva of men by means of thin-layer chromatography and mass spectrometry.

Authors:  W W Just; N Filipovic; G Werner
Journal:  J Chromatogr       Date:  1974-09-11

7.  Metabolism of tetrahydrocannabinol by the small intestine.

Authors:  M L Greene; D R Saunders
Journal:  Gastroenterology       Date:  1974-03       Impact factor: 22.682

Review 8.  Marijuana's interaction with brain reward systems: update 1991.

Authors:  E L Gardner; J H Lowinson
Journal:  Pharmacol Biochem Behav       Date:  1991-11       Impact factor: 3.533

9.  Cannabinoid receptor localization in brain.

Authors:  M Herkenham; A B Lynn; M D Little; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

10.  Urine drug testing of chronic pain patients: licit and illicit drug patterns.

Authors:  Edward J Cone; Yale H Caplan; David L Black; Timothy Robert; Frank Moser
Journal:  J Anal Toxicol       Date:  2008-10       Impact factor: 3.367

View more
  20 in total

Review 1.  Pharmacological evidence of medicinal cannabis in oncology: a systematic review.

Authors:  Danielle Brown; Michael Watson; Janet Schloss
Journal:  Support Care Cancer       Date:  2019-05-06       Impact factor: 3.603

2.  Quantitative mass spectrometry of unconventional human biological matrices.

Authors:  Ewelina P Dutkiewicz; Pawel L Urban
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2016-10-28       Impact factor: 4.226

3.  Long-term stability of cannabinoids in oral fluid after controlled cannabis administration.

Authors:  Karl B Scheidweiler; Maria Andersson; Madeleine J Swortwood; Cristina Sempio; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2016-09-13       Impact factor: 3.345

4.  Detection of carbamazepine in saliva based on surface-enhanced Raman spectroscopy.

Authors:  Ning Chen; Yanbing Yuan; Ping Lu; Luyao Wang; Xuedian Zhang; Hui Chen; Pei Ma
Journal:  Biomed Opt Express       Date:  2021-11-18       Impact factor: 3.732

5.  Impact of oral fluid collection device on cannabinoid stability following smoked cannabis.

Authors:  Sébastien Anizan; Mateus M Bergamaschi; Allan J Barnes; Garry Milman; Nathalie Desrosiers; Dayong Lee; David A Gorelick; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-07-03       Impact factor: 3.345

6.  Chronic periodontitis can affect the levels of potential oral cancer salivary mRNA biomarkers.

Authors:  Y-S L Cheng; L Jordan; H-S Chen; D Kang; L Oxford; J Plemons; H Parks; T Rees
Journal:  J Periodontal Res       Date:  2016-08-23       Impact factor: 4.419

7.  Mobile contingency management as an adjunctive treatment for co-morbid cannabis use disorder and cigarette smoking.

Authors:  Jean C Beckham; Kelsie A Adkisson; Jeffrey Hertzberg; Nathan A Kimbrel; Alan J Budney; Robert S Stephens; Scott D Moore; Patrick S Calhoun
Journal:  Addict Behav       Date:  2017-12-06       Impact factor: 3.913

8.  Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials.

Authors:  Nathaniel L Baker; Kevin M Gray; Brian J Sherman; Kristen Morella; Gregory L Sahlem; Amanda M Wagner; Aimee L McRae-Clark
Journal:  Drug Alcohol Depend       Date:  2018-04-16       Impact factor: 4.492

9.  Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges.

Authors:  Rachel L Tomko; Kevin M Gray; Marilyn A Huestis; Lindsay M Squeglia; Nathaniel L Baker; Erin A McClure
Journal:  Curr Addict Rep       Date:  2019-11-19

10.  Study of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extraction FROM dried oral fluid spots (DOFS) and LC-MS/MS detection.

Authors:  Roberta Gorziza; Joseph Cox; Renata Pereira Limberger; Luis E Arroyo-Mora
Journal:  J Cannabis Res       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.